Skip to content
DraconiticResearch
Search Sources API
197,693 studies31 sourcesUpdated 3 min ago
Peer-reviewedCC BY-NC 4.0Open Heart

Association of exercise with phenotype and arrhythmic outcomes in gene-elusive arrhythmogenic cardiomyopathy

  1. 1Department of Cardiology, University Hospital Zurich, Zürich, Switzerland
  2. 2Center for Translational and Experimental Cardiology (CTEC), University of Zurich, Zürich, Switzerland

Abstract

Background: Arrhythmogenic cardiomyopathy (ACM) is a leading cause of sudden cardiac death in young adults and athletes. It is mostly genetically determined, with causal variants predominantly affecting desmosomal genes. Approximately one-third of patients remain gene-elusive despite extensive testing. Gene-elusive patients often report significantly higher lifetime exercise exposure than those with desmosomal ACM, suggesting a disproportionate role of exercise in this subgroup, also termed ‘exercise-induced ACM’. Yet, the effect of exercise history on the clinical characteristics and prognosis of this phenotype remains scarce.

Methods: In this retrospective, single-centre cohort study, we included patients with definite or borderline ACM and negative genetic testing for ACM-associated genes. Exercise exposure was quantified with a standardised sports activity survey or from medical records. Competitive athletes were defined by an exercise exposure ≥24 metabolic equivalent of task-hour/week for ≥6 consecutive years and regular participation in competitive events. Life-threatening ventricular arrhythmias (LTVA) were defined as sustained ventricular tachycardia, ventricular fibrillation or appropriate implantable cardioverter-defibrillator therapies.

Results: 46 patients (26 athletes, 20 non-athletes) were followed for a median of 7.5 years. At diagnosis, most athletes (77%) had definite right-ventricular ACM, compared with only 40% of non-athletes (p=0.025). Compared with non-athletes, athletes had a larger end-diastolic right-ventricular volume, while other imaging findings did not differ significantly. Athletes showed a distinct electrical phenotype with a shorter QTc (424 ms vs 449 ms, p<0.001), more T-wave inversions (4.0 vs 2.40, p=0.047) and a higher hazard of LTVA, death or heart transplantation during follow-up (HR 2.67, 95% CI 1.11 to 6.44, p=0.029).

Conclusion: In gene-elusive ACM, a history of competitive athletic participation was associated with more extensive repolarisation abnormalities, larger right ventricular volumes and a higher hazard of adverse outcomes during follow-up. These associations require validation in prospective multicentre cohorts, particularly regarding the relationship between exercise exposure and arrhythmic risk.

Related

  1. Elimination of Epicardial Late Potentials by Endocardial Ablation in Arrhythmogenic Right Ventricular Cardiomyopathy
    A Hermida, C Pavone, R Sauve +13
    EP-EuropacePeer-reviewedCC BYGeneral biologyCardiovascular medicineHAL
  2. Incremental prognostic value of hepatic tissue alterations derived from cardiac magnetic resonance imaging for arrhythmogenic right ventricular cardiomyopathy: a case-control study
    Xiahui Tian, Yuelong Yang, Guanyu Lu +8
    Quantitative imaging in medicine and surgeryPeer-reviewedCC BY-NC-NDFull textMedical imaging & radiologyEurope PMC
  3. Clinical relevance of lead-induced tricuspid regurgitation after transvenous implantable cardioverter-defibrillator implantation in arrhythmogenic cardiomyopathy
    Federico Migliore, Raimondo Pittorru, Alberto Cipriani +11
    EuropacePeer-reviewedCC BY 4.0Full textCardiovascular medicinePMC
  4. Diverse Clinical Spectrum of TTN-Truncation Variant Cardiomyopathy: A Case Series Illustrating Asymptomatic, Arrhythmic, Recurrent Takotsubo, and Inflammatory Phenotypes.
    Mehran Jalilzadehbinazar, Craig K Reiss, Shane J LaRue +2
    CureusPeer-reviewedCC BYFull textCardiovascular medicineEurope PMC
  5. Pathogenic variants in myoferlin (MYOF) cause arrhythmogenic cardiomyopathy
    A. Kirillova, M. Aytekin, I. Chan +29
    medRxivPreprintAll rights reservedFull textCardiovascular medicinemedRxiv
BibTeX
@article{tramer2026association,
  title = {{Association of exercise with phenotype and arrhythmic outcomes in gene-elusive arrhythmogenic cardiomyopathy}},
  author = {Lucas Tramèr and Deniz Akdis-Weidmann and Thierry G Donati and Andrea Agbariah and Fu Guan and Corinna Brunckhorst and Robert Manka and Felix C Tanner and Ardan M Saguner and Firat Duru},
  journal = {Open Heart},
  year = {2026},
  month = oct,
  doi = {10.1136/openhrt-2026-004480},
  url = {https://doi.org/10.1136/openhrt-2026-004480},
  note = {CC BY-NC 4.0},
}
RIS
TY  - JOUR
TI  - Association of exercise with phenotype and arrhythmic outcomes in gene-elusive arrhythmogenic cardiomyopathy
AU  - Lucas Tramèr
AU  - Deniz Akdis-Weidmann
AU  - Thierry G Donati
AU  - Andrea Agbariah
AU  - Fu Guan
AU  - Corinna Brunckhorst
AU  - Robert Manka
AU  - Felix C Tanner
AU  - Ardan M Saguner
AU  - Firat Duru
PY  - 2026
DA  - 2026/10/26
JO  - Open Heart
DO  - 10.1136/openhrt-2026-004480
UR  - https://doi.org/10.1136/openhrt-2026-004480
AB  - Background: Arrhythmogenic cardiomyopathy (ACM) is a leading cause of sudden cardiac death in young adults and athletes. It is mostly genetically determined, with causal variants predominantly affecting desmosomal genes. Approximately one-third of patients remain gene-elusive despite extensive testing. Gene-elusive patients often report significantly higher lifetime exercise exposure than those with desmosomal ACM, suggesting a disproportionate role of exercise in this subgroup, also termed ‘exercise-induced ACM’. Yet, the effect of exercise history on the clinical characteristics and prognosis of this phenotype remains scarce.  Methods: In this retrospective, single-centre cohort study, we included patients with definite or borderline ACM and negative genetic testing for ACM-associated genes. Exercise exposure was quantified with a standardised sports activity survey or from medical records. Competitive athletes were defined by an exercise exposure ≥24 metabolic equivalent of task-hour/week for ≥6 consecutive years and regular participation in competitive events. Life-threatening ventricular arrhythmias (LTVA) were defined as sustained ventricular tachycardia, ventricular fibrillation or appropriate implantable cardioverter-defibrillator therapies.  Results: 46 patients (26 athletes, 20 non-athletes) were followed for a median of 7.5 years. At diagnosis, most athletes (77%) had definite right-ventricular ACM, compared with only 40% of non-athletes (p=0.025). Compared with non-athletes, athletes had a larger end-diastolic right-ventricular volume, while other imaging findings did not differ significantly. Athletes showed a distinct electrical phenotype with a shorter QTc (424 ms vs 449 ms, p<0.001), more T-wave inversions (4.0 vs 2.40, p=0.047) and a higher hazard of LTVA, death or heart transplantation during follow-up (HR 2.67, 95% CI 1.11 to 6.44, p=0.029).  Conclusion: In gene-elusive ACM, a history of competitive athletic participation was associated with more extensive repolarisation abnormalities, larger right ventricular volumes and a higher hazard of adverse outcomes during follow-up. These associations require validation in prospective multicentre cohorts, particularly regarding the relationship between exercise exposure and arrhythmic risk.
SN  - 2053-3624
ER  -